7th Annual Genome Editing US Congress8 - 9 July 2021 | Boston, USA

With gene editing tools becoming advanced enough to realise therapeutic potential, decision-makers working in academia and pharma are looking to consolidate their techniques to facilitate disease modelling, drug development and clinical studies.

The NextGen Omics US: In-Person event includes...

Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.

Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.

Last Year's Agenda at a Glance

Day One

  • Genome Editing Technologies & Techniques
  • Drug Discovery & Development Applications in In Vivo Therapeutics

Day Two

  • Drug Discovery & Development – Target Identification and Validation
  • Non-Human Models in Diagnostics & Therapeutics

Live Webinar

Higher Quality Nucleic Acid Extraction from FFPE Tissue & Other Challenging Samples Using the Ionic™ Purification System

hosted by Klint Rose, Chief Scientific Officer, Purigen Biosystems

Wednesday 27th May
16:00 BST